Imperial College London

The Centre for Psychedelic Research studies the action (in the brain) and clinical use of psychedelics, with a focus on depression.

Imperial College London’s Centre for Psychedelic Research

The center is part of Imperial College London, one of the top universities in the world. It was started with over £3 million (€­3.2/$3.8m) from five founding donors. The center builds on the world that has previously been done within Imperial College London.

Robin Carhart-Harris leads the research group and David Nutt (Drug Science) and Amanda Feilding (Beckley Foundation) are part of the team. Under Carhart-Harris the “[center] focuses on two main research themes: the use of psychedelics in mental health care; and as tools to probe the brain’s basis of consciousness. It will also investigate their potential for treating other conditions, including anorexia.”

The founding donors are: Anton Bilton, Shamil Chandaria (Ad Astra Trust), Tim Ferriss, The Nikean Foundation, The Tamas Family.

Key Staff

See the full team and collaborators here.


You can find all the research that has been done by the group on their website. Some of the most notable papers are:


The news below is a small selection of the articles by on the Imperial College London’s website.

Company Information

Imperial College London Website

January, 2016


Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships